P2Y purinergic receptors regulate the growth of human melanomas

被引:59
作者
White, N
Ryten, M
Clayton, E
Butler, P
Burnstock, G
机构
[1] UCL Royal Free & Univ Coll Med Sch, Autonom Neurosci Inst, London NW3 2PF, England
[2] UCL Royal Free Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England
[3] Mt Vernon Hosp, RAFT Inst Plast Surg, Northwood HA6 2RN, Middx, England
关键词
cancer; melanoma; P2Y receptor; ATP;
D O I
10.1016/j.canlet.2004.11.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adenosine 5'-triphosphate is known to function as a potent extracellular messenger producing its effects via a distinct family of cell surface receptors. Different receptor subtypes have been shown to modulate different cellular functions such as proliferation, differentiation and apoptosis. We investigated the functional expression and proliferative action of metabotropic P2Y receptors in human melanoma tissue and cells. Expression of functional P2Y(1), P2Y(2) and P2Y(6) receptor subtypes was established by reverse transcriptase polymerase chain reaction, immunohistochemistry and intracellular calcium measurements using a Fluorometric Imaging Plate Reader. Incubation of A375 melanoma cells with the P2Y, receptor- selective agonist 2-methylthioadenosine-5-diphosphate caused a decrease in cell number which was dose-dependent, whereas incubation with the P2Y(2) receptor agonist uridine triphosphate caused a dose-dependent increase in cell number. The action of extracellular nucleotides on P2Y receptors was shown to mediate the growth of melanomas and the P2Y, receptor is a putative target for melanoma therapy. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:81 / 91
页数:11
相关论文
共 43 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   ATP in the treatment of advanced cancer [J].
Abraham, EH ;
Salikhova, AY ;
Rapaport, E .
EXTRACELLULAR NUCLEOTIDES AND NUCLEOSIDES: RELEASE, RECEPTORS, AND PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS, 2003, 54 :415-452
[3]   Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells [J].
Adrian, K ;
Bernhard, MK ;
Breitinger, HG ;
Ogilvie, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (01) :127-138
[4]   INOSITOL TRISPHOSPHATE AS A 2ND MESSENGER IN SIGNAL TRANSDUCTION [J].
BERRIDGE, MJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 494 :39-51
[5]   CAPACITATIVE CALCIUM-ENTRY [J].
BERRIDGE, MJ .
BIOCHEMICAL JOURNAL, 1995, 312 :1-11
[6]   Purinergic signaling and vascular cell proliferation and death [J].
Burnstock, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (03) :364-373
[7]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[8]   The past, present and future of purine nucleotides as signalling molecules [J].
Burnstock, G .
NEUROPHARMACOLOGY, 1997, 36 (09) :1127-1139
[9]  
Burnstock G., 1978, CELL MEMBRAIN RECEPT, P107, DOI DOI 10.1016/0014-5793(79)81367-8
[10]   EXTRACELLULAR ATP STIMULATES CALCIUM INFLUX IN NEUROBLASTOMA X GLIOMA HYBRID NG108-15 CELLS [J].
CHUEH, SH ;
KAO, LS .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (05) :1782-1788